By Rentschler Biopharma…
To get in touch with Rentschler presenting Fusion Protein insights at ISPE 2017 Europe Biotechnology Conference in Dublin, simply fill out the form below.
Subscribe to Supplier
Rentschler presenting Fusion Protein insights at ISPE 2017 Europe Biotechnology Conference in Dublin
Laupheim, Germany: Full-service biopharmaceutical contract development and manufacturing organization (CDMO) Rentschler Biotechnologie GmbH will bring insights on advanced fusion protein manufacturing to the ISPE 2017 Europe Biotechnology Conference later this month.
Rentschler will be represented by its Chief Scientific Officer, Dr. Stefan R. Schmidt, who will deliver a lecture on fusion proteins as the first address of the conference’s Track 1: ‘Technology, Innovation and the Factory of the Future’ on Day One of the event.
Advanced bioprocessing expertise
“This ISPE conference connects us with biotech and pharma companies and consultants, all of whom can benefit from Rentschler’s advanced capabilities and expertise in development and manufacturing of fusion proteins and other therapeutic proteins,” commented Dr. Stefan Schmidt.
The conference will take place in Dublin, Ireland from 26th to 27th September 2017.
About Rentschler Biotechnologie
Rentschler, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and manufacturing of biopharmaceuticals as well as for related consulting activities in terms of project management and regulatory support.
The Company’s clients include innovative biotech companies and major pharmaceutical companies around the world. Many years of experience and excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler’s high quality standards.
Rentschler Biotechnologie is a family-owned company employing approximately 750 people.
About ISPE Europe Biotechnology Conference 2017
The International Society for Pharmaceutical Engineering organises a series of conferences worldwide, of which the ISPE Europe Conference on Biotechnology focuses on process science and technological advancements and trends to approach future manufacturing challenges in the biotechnology industry.
The 2017 conference is a two-day event, opening September 26 at the Crown Plaza Conference in Northwood Park, Dublin. The conference will explore a number of themes including biotechnology factories of the future, megatrends in technology and regulatory development, and capacity constraints in biologics.
The conference, which also features a co-located exhibition, is organised by ISPE with more information at: https://www.ispe.org/conferences/2017-europe-biotechnology